Aardvark Therapeutics, Inc. Common Stock (AARD) — Financial Flexibility Index
Aardvark Therapeutics, Inc. Common Stock (AARD) has a Financial Flexibility Index of -1.71x as of September 2025. Free cash flow of $-18.51 Million (operating CF $-18.52 Million minus capex $4.00K) represents -2% of total liabilities ($10.85 Million). Check tangible equity quality of Aardvark Therapeutics, Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aardvark Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Aardvark Therapeutics, Inc. Common Stock across 3 annual periods. For the full cash flow conversion analysis, see Aardvark Therapeutics, Inc. Common Stock cash flow conversion.
Annual Financial Flexibility Index for Aardvark Therapeutics, Inc. Common Stock (2022–2024)
Year-by-year free cash flow to debt coverage for Aardvark Therapeutics, Inc. Common Stock. Explore Aardvark Therapeutics, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.14x | $-17.98 Million | $-18.09 Million | $132.15 Million | ▼ -5.9% |
| 2023 | -0.13x | $-5.82 Million | $-5.82 Million | $45.34 Million | ▲ +45.6% |
| 2022 | -0.24x | $-10.54 Million | $-10.54 Million | $44.68 Million | — |